Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering
Authors
Keywords
CRISPR-Cas9, CAR-T cells, precision genome editing, CRISPR delivery, virus-like particles, viral engineering
Journal
Cell Reports
Volume 35, Issue 9, Pages 109207
Publisher
Elsevier BV
Online
2021-06-01
DOI
10.1016/j.celrep.2021.109207
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28
- (2021) Yannick D. Muller et al. Frontiers in Immunology
- The promise and challenge of therapeutic genome editing
- (2020) Jennifer A. Doudna NATURE
- CRISPR-engineered T cells in patients with refractory cancer
- (2020) Edward A. Stadtmauer et al. SCIENCE
- The Emerging Landscape of Immune Cell Therapies
- (2020) Evan W. Weber et al. CELL
- The delivery challenge: fulfilling the promise of therapeutic genome editing
- (2020) Joost van Haasteren et al. NATURE BIOTECHNOLOGY
- Highly efficient ‘hit-and-run’ genome editing with unconcentrated lentivectors carrying Vpr.Prot.Cas9 protein produced from RRE-containing transcripts
- (2020) Ivana Indikova et al. NUCLEIC ACIDS RESEARCH
- Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
- (2020) Tuo Wei et al. Nature Communications
- CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
- (2020) Jessica Wagner et al. MOLECULAR THERAPY
- A New Class of Medicines through DNA Editing
- (2019) Matthew H. Porteus NEW ENGLAND JOURNAL OF MEDICINE
- Gene editing for immune cell therapies
- (2019) Stefanie R. Bailey et al. NATURE BIOTECHNOLOGY
- Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient ‘hit-and-run’ genome editing
- (2019) Pin Lyu et al. NUCLEIC ACIDS RESEARCH
- A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing
- (2019) Guojun Chen et al. Nature Nanotechnology
- Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency
- (2019) David N. Nguyen et al. NATURE BIOTECHNOLOGY
- Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing
- (2018) Romain Rouet et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9/Cpf1 ribonucleoproteins in hard-to-modify cells
- (2018) Thomas Del’Guidice et al. PLoS One
- Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide
- (2018) Hong-Xia Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reprogramming human T cell function and specificity with non-viral genome targeting
- (2018) Theodore L. Roth et al. NATURE
- CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions
- (2018) Wanghong Hu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins
- (2018) Philippe E. Mangeot et al. Nature Communications
- Therapeutic T cell engineering
- (2017) Michel Sadelain et al. NATURE
- Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes
- (2017) Brett T Staahl et al. NATURE BIOTECHNOLOGY
- Human antibody-based chemically induced dimerizers for cell therapeutic applications
- (2017) Zachary B Hill et al. Nature Chemical Biology
- CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
- (2017) Levi J. Rupp et al. Scientific Reports
- Lentivirus pre-packed with Cas9 protein for safer gene editing
- (2016) J G Choi et al. GENE THERAPY
- Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA
- (2016) Christopher D Richardson et al. NATURE BIOTECHNOLOGY
- Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA
- (2014) S. Ramakrishna et al. GENOME RESEARCH
- Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases
- (2014) Yujia Cai et al. eLife
- DNA transposition by protein transduction of the piggyBac transposase from lentiviral Gag precursors
- (2013) Yujia Cai et al. NUCLEIC ACIDS RESEARCH
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Therapeutic potential of HIV protease-activable CASP3
- (2012) Kosuke Miyauchi et al. Scientific Reports
- Protein transduction by pseudotyped lentivirus-like nanoparticles
- (2011) T Aoki et al. GENE THERAPY
- Efficient gene targeting mediated by a lentiviral vector-associated meganuclease
- (2011) Araksya Izmiryan et al. NUCLEIC ACIDS RESEARCH
- Site-specific Gene Insertion Mediated by a Cre-loxP-carrying Lentiviral Vector
- (2010) Gilles Michel et al. MOLECULAR THERAPY
- Production of HIV-1 Integrase Fusion Protein-Carrying Lentiviral Vectors for Gene Therapy and Protein Transduction
- (2009) Diana Schenkwein et al. HUMAN GENE THERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started